BioInfra Co.,Ltd. Logo

BioInfra Co.,Ltd.

Develops multi-biomarker blood tests for early cancer screening and gene treatments.

199730 | KO

Overview

Corporate Details

ISIN(s):
KR7199730003
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 흥덕중앙로 120 4층, 5층, 용인시

Description

BioInfra Co., Ltd. is a biotechnology and healthcare company specializing in innovative solutions for disease prevention and early detection, with a primary focus on oncology. The company's core technology is a proprietary multi-biomarker blood test for the early screening of eight major cancers, including lung, liver, stomach, colorectal, prostate, breast, pancreatic, and ovarian cancer. This in vitro diagnostic tool analyzes a small blood sample to assess cancer risk, aiming to improve patient outcomes through early intervention. Beyond diagnostics, BioInfra also engages in pharmaceutical research and development, offering clinical research services and developing cancer gene treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-03-15 00:00
[기재정정]사업보고서 (2023.12)
Korean HTML 841.8 KB
2024-03-15 00:00
[기재정정]사업보고서 (2023.12)
Korean HTML 842.3 KB
2024-03-15 00:00
[기재정정]사업보고서 (2023.12)
Korean HTML 842.8 KB
2024-03-11 00:00
의결권대리행사권유참고서류
Korean HTML 96.9 KB
2024-03-08 00:00
현금ㆍ현물배당결정
Korean HTML 8.5 KB
2024-03-08 00:00
주주총회소집결의
Korean HTML 14.5 KB
2024-03-08 00:00
주주총회소집공고
Korean HTML 178.2 KB
2024-03-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 20.9 KB
2024-03-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 20.9 KB
2024-01-26 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean HTML 11.0 KB
2023-12-12 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2023-11-14 00:00
분기보고서 (2023.09)
Korean HTML 705.6 KB
2023-10-05 00:00
신규시설투자등
Korean HTML 6.9 KB
2023-08-11 00:00
반기보고서 (2023.06)
Korean HTML 646.5 KB
2023-05-15 00:00
분기보고서 (2023.03)
Korean HTML 655.7 KB

Automate Your Workflow. Get a real-time feed of all BioInfra Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioInfra Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioInfra Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.